MERCK & CO NEWS
Merck & Co., Inc. or Merck Sharp and Dohme (as it is known outside the USA and Canada) is a US pharmaceutical company. It was originally the US subsidiary of the German company, Merck KGaA. In common with many other German assets in the United States, Merck & Co. was confiscated in 1917 during First World War and set up as an independent company. It is now one of the top 5 largest pharmaceutical companies in the world both by capital and revenue.
Equifax ID Patrol - Sponsored Link
Mon, 18 Aug 2008 14:44:00 GMT
Ad - Protect the power of your credit and your identity.
[read
more...]
The Merck Index Women in Chemistry Scholarships to be Presented at American Chemical Society National Meeting
Mon, 18 Aug 2008 14:44:00 GMT
- Merck & Co. Inc. today announced the winners of the second annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in medicinal or synthetic organic
[read
more...]
The Merck Index Women in Chemistry Scholarships to be Presented at American Chemical Society National Meeting
Mon, 18 Aug 2008 14:43:00 GMT
, 9:30 AM EST News source: Business Wire Merck & Co. Inc. today announced the winners of the second annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in
[read
more...]
The Merck Index Women in Chemistry Scholarships to be Presented at American Chemical Society National Meeting
Mon, 18 Aug 2008 13:55:00 GMT
WHITEHOUSE STATION, N.J. - (Business Wire) Merck & Co. Inc. today announced the winners of the second annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in
[read
more...]
The Merck Index Women in Chemistry Scholarships to be Presented at American Chemical Society National Meeting
Mon, 18 Aug 2008 13:49:00 GMT
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck & Co. Inc. today announced the winners of the second annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in
[read
more...]
The Merck Index Women in Chemistry Scholarships to be Presented at American Chemical Society National Meeting
Mon, 18 Aug 2008 13:47:00 GMT
WHITEHOUSE STATION, N.J. -- (Business Wire) Merck & Co. Inc. today announced the winners of the second annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in
[read
more...]
The Merck Index Women in Chemistry Scholarships to be Presented at American Chemical Society National Meeting
Mon, 18 Aug 2008 13:46:00 GMT
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck & Co. Inc. today announced the winners of the second annual Merck Index Women in Chemistry Scholarship program. The program is designed to foster support for women choosing to pursue advanced degrees in
[read
more...]
Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE
Mon, 18 Aug 2008 11:44:00 GMT
BETHESDA, Md., Aug. 18 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, will host a webcast and conference call this
[read
more...]
Company Analysis, News & DD - 2004
Mon, 18 Aug 2008 02:57:00 GMT
One of the things I tend to do when I identify an investment method that makes sense to me and that I may want to incorporate into my investing tool kit, is go back to the beginning of it's Board and read forward. Being the compulsive organizer I am
[read
more...]
Orchid Chemicals to develop and manufacture an anti-coagulant drug candidate
Sun, 17 Aug 2008 13:29:00 GMT
Orchid Chemicals & Pharmaceuticals, engaged is bulk drugs business, has informed that it will develop and manufacture an anti-coagulant drug candidate, which was initially discovered and developed through phase I by U. S. pharmaceutical giant Merck
[read
more...]
HPV Vaccine Causes 21 Deaths and Counting - CDC Study Launched
Sun, 17 Aug 2008 12:56:00 GMT
New England Journal of Medicine claims that only about 10% of drug induced side effects are reported OTTAWA, August 14, 2008 (LifeSiteNews.com) - Critics say that the reasons to avoid using the HPV vaccine, Gardasil, continue to pile up in the form of
[read
more...]
Three HIV Drug Makers Promise More Help to ADAP and HIVers With Private Insurance
Sat, 16 Aug 2008 05:33:00 GMT
San Francisco, Calif. -- and Baltimore MD. The Fair Pricing Coalition (FPC), a group of community-based activists formed ten years ago to contain the escalating prices of HIV drugs, announced today the interim results of a campaign aimed at stabilizing
[read
more...]
On-TIME 2 in print: Acute STEMI gains with prehospital triple antiplatelet therapy
Fri, 15 Aug 2008 23:01:00 GMT
London, UK - The addition of 'high-bolus-dose' tirofiban (Aggrastat, Merck) to dual antiplatelet therapy in the prehospital setting significantly improved ST-segment resolution both before and after primary PCI in patients with acute ST-elevation MI
[read
more...]
Drug Ads Losing Recall Effectiveness Among Consumers
Fri, 15 Aug 2008 19:17:00 GMT
If you think that marketing in the drug category is becoming less interesting and more monotonous, you're right. A ranking of the most-recalled prescription drug ads shows that prescription drug ads became less memorable for consumers between this year
[read
more...]
The BRIC Countries: Opportunities for Regulated Market Players
Fri, 15 Aug 2008 18:39:00 GMT
The author outlines the opportunities and challenges for manufacturers aiming to enter the BRIC-country markets. Pharmaceutical Technology Pages | 1 | 2 | 3 | 4 | 5 | 6 From the perspective of active ingredient- and finished-dose manufacturers based in
[read
more...]
Zacks Analyst Blog Highlights: UBS AG, BlackRock Inc., Ev3 Inc., Merck & Co. and Chunghwa Telecom Co. Ltd.
Fri, 15 Aug 2008 17:12:00 GMT
CHICAGO-- (BUSINESS WIRE) -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the
[read
more...]
Merck headquarters to build largest solar power system
Fri, 15 Aug 2008 16:31:00 GMT
Aug. 15 -- Pharmaceutical firm Merck & Co. Inc. will boast the largest ground-mounted solar power system in the eastern United States at its world headquarters in Whitehouse Station, N.J. The 1.6-megawatt solar tracking power system will consist of
[read
more...]
Inovio Biomedical Expands In Vivo Electroporation License with International AIDS Vaccine Initiative for HIV Vaccine Research
Fri, 15 Aug 2008 15:01:00 GMT
DNA Vaccine Delivery Technology Shows Promise in Inducing Stronger Immune Responses SAN DIEGO-- (BUSINESS WIRE) -- Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based
[read
more...]
1.6-MW Solar System Being Built at Merck Headquarters
Fri, 15 Aug 2008 12:52:00 GMT
A 1.6-megawatt (MW) SunPower solar tracking power system, comprising approximately 7,000 solar panels, will cover seven acres of Merck's 1,000-acre site. The system will be owned and operated by UTC Power, which will supply solar power to Merck under a
[read
more...]
Nielsen IAG: Drug Spots Lose Potency
Fri, 15 Aug 2008 12:01:00 GMT
Extract not available.
[read
more...]
Zacks Analyst Blog Highlights: UBS AG, BlackRock Inc., Ev3 Inc., Merck & Co. and Chunghwa Telecom Co. Ltd.
Fri, 15 Aug 2008 10:47:00 GMT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: UBS AG (UBS),
[read
more...]
Diakron licenses anticoagulant drug candidate from Merck & Co
Fri, 15 Aug 2008 10:45:00 GMT
Under the terms of the agreement, Diakron has the exclusive rights to develop, and, if approved, market and distribute the compound worldwide. In a simultaneous transaction, Orchid Chemicals & Pharmaceuticals has signed an agreement to partner with
[read
more...]
Zacks Analyst Blog Highlights: UBS AG, BlackRock Inc., Ev3 Inc., Merck & Co. and Chunghwa Telecom Co. Ltd.
Fri, 15 Aug 2008 10:23:00 GMT
CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the
[read
more...]
Zacks Analyst Blog Highlights: UBS AG, BlackRock Inc., Ev3 Inc., Merck & Co. and Chunghwa Telecom Co. Ltd.
Fri, 15 Aug 2008 10:14:00 GMT
CHICAGO - (Business Wire) Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the
[read
more...]
Largest Ground-Mounted Solar Power Tracking System East of Mississippi River Being Built at Merck &
Fri, 15 Aug 2008 05:26:00 GMT
WHITEHOUSE STATION, N.J., Aug. 14 /PRNewswire-FirstCall/ -- By the end of 2008, the world headquarters of Merck & Co., Inc. in Whitehouse Station, N.J., will have the largest ground-mounted solar power tracking system in the eastern half of the
[read
more...]
Africa 'must not stop HIV vaccine trials'
Fri, 15 Aug 2008 05:24:00 GMT
Anzala: 'We cannot stop now. We are ready and are going to be a part of the solution' SciDev.Net/Mohammed Yahia [MEXICO CITY] Shutting down clinical trial centres in Africa in response to continued failure of HIV vaccine candidates would be a big
[read
more...]
Vaccine Production Issues for Merck Are Subsiding
Fri, 15 Aug 2008 04:07:00 GMT
Merck has resolved a warning letter citing GMP violations at its vaccine operations in West Point, Pa., and resolved supply constraints for bulk varicella, which had affected sales of certain vaccines.
[read
more...]
CSL's big blood play
Thu, 14 Aug 2008 23:50:00 GMT
Shares in pharmaceutical maker CSL Ltd, maker of the cervical cancer vaccine Gardasil, have been placed in a trading halt, pending the completion of a huge $1.5 billion capital raising to fund a $3.5 billion deal in the US to expand its dominant presence
[read
more...]
Merck spends nearly $1.2 million on lobbying in 2Q
Thu, 14 Aug 2008 23:42:00 GMT
Extract not available.
[read
more...]
Diakron licenses anticoagulant drug candidate from Merck & Co
Thu, 14 Aug 2008 23:40:00 GMT
Diakron Pharmaceuticals has announced the signing of an exclusive license agreement for an investigational oral anticoagulant drug candidate discovered and developed through Phase I clinical trials by Merck & Co.Under the terms of the agreement, Diakron
[read
more...]
Drug Ads Losing Recall Effectiveness Among Consumers
Thu, 14 Aug 2008 22:59:00 GMT
Extract not available.
[read
more...]
powered by zFeeder
Blogos.net